Nobel Hunting for Acquisitions?

Last Updated: Jun 10, 2008

Swiss dental implant maker Nobel Biocare (NOBN.VX) expects an improvement in business in the second half, the company’s chief executive was quoted as saying in a newspaper interview, boosting the company’s shares.

“The second half of the year should already be better,” Nobel Biocare CEO Domenico Scala told Swiss weekly newspaper Handelszeitung, according to an interview released on Tuesday, a day ahead of the paper’s publication.

The company has shocked investors with a series of profit warnings in recent months, missing targets as customers cut spending due to economic uncertainty.

Scala said the company’s current forecast would remain valid after the second quarter if the overall economy did not deteriorate further.

Nobel Biocare shares have lost around 36 percent so far this year, sparking speculation that the world’s largest maker of dental implants could be taken over.

“We have the financial as well as the strategic resources to form our future alone,” Scala told the newspaper when asked about the market talk. The company was eyeing acquisitions itself, Scala said: “It is clear that growth will also happen through acquisitions.”
Nobel Biocare was looking for smaller targets in the range of 50 to 100 million Swiss francs ($48.45 to $96.90 million) in the field of ceramics or software, Scala said.

(Source: Reuters, Reporting by Sven Egenter; Editing by Will Waterman and David Holmes)

3 Comments on Nobel Hunting for Acquisitions?

Comments Closed

New comments are currently closed for this post.

Sebastian Fernandez

11/19/2008

I believe it will be very difficult to get Nobel Biocare new investors if it continues with this policy of excessive spending, it is clear that the profits of the company are good, but when comparing costs, as we are losing balance, for the sample of the subsidiary Nobel Biocare Colombia has one of the most extravagant spending and one of the most deficient of all governments Nobel Biocare, but that does not seem to matter to the CEO as the manager continues to spend and squander hands full. That's why it will be difficult to get investors sr Domenico Scala

bill withers

12/04/2008

A company like Nobel Biocare must feel the negative impact it has had the fall of the stock market and more so when its executive staff make mistakes as serious as the manager of the subsidiary of colombia which is offering discounts above 60%, so it is impossible sustain such a company, where costs are fired and accounts receivable are in serious trouble at the inefficiency of the manager and his team of collaborators

Dr. P.P.

03/24/2009

Can someone tell me if is it true that a Replace implant cost 90 dollars in Argentina? It cost 260â‚¬ in my country, I can fly to Argentina, Have a nice bife de chorizo with a good wine, visit Bariloche and come back with some implants and I will save money by the way!!!! The same in Colombia but I will have pisco sauer then. Best regards. Dr P.P.

« nobel profit falls nobel healing abutment wont engage implant removal scan body recommendations »